scholarly journals Randomized controlled multicentre study comparing biological mesh closure of the pelvic floor with primary perineal wound closure after extralevator abdominoperineal resection for rectal cancer (BIOPEX-study)

BMC Surgery ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Gijsbert D Musters ◽  
Willem A Bemelman ◽  
Robbert JI Bosker ◽  
Jacobus WA Burger ◽  
Peter van Duijvendijk ◽  
...  
2017 ◽  
Vol 265 (6) ◽  
pp. 1074-1081 ◽  
Author(s):  
Gijsbert D. Musters ◽  
Charlotte E. L. Klaver ◽  
Robbert J. I. Bosker ◽  
Jacobus W. A. Burger ◽  
Peter van Duijvendijk ◽  
...  

2018 ◽  
Vol 36 (4) ◽  
pp. 281-288 ◽  
Author(s):  
Naseer Baloch ◽  
Per J. Nilsson ◽  
Caroline Nordenvall ◽  
Mirna Abraham-Nordling

Aims: This study aimed to describe the short-term perineal healing rates in patients with perineal reconstruction using a biological mesh following extralevator abdominoperineal excision (elAPE). Methods: In a retrospective, descriptive single-centre cohort study, 88 consecutive patients treated with elAPE and perineal closure using a biological mesh between January 2011 and December 2015 were reviewed. All available data from electronic hospital records was collected. Patients were followed for 1 year following surgery and perineal wound status assessed at 3 months and at 1 year. Results: In total, 63 patients were male and all but 8 patients were treated for primary rectal cancer. All patients but 3 had received radiotherapy prior to surgery. Multivisceral excisions were performed in 19 patients. Omentoplasty was performed in 55 patients and 3 different types of meshes were used during the study period. At 3 months, 58 patients (66%) had a healed perineum. No association was detected between patient, tumour or perioperative characteristics and perineal wound status at 3 months. At 1 year, 4 patients were deceased and among the remaining 84, the perineal wound was healed in 77 patients (92%). Conclusion: The use of biological meshes in perineal reconstruction following elAPE is feasible and safe, and the perineal wound is healed in the majority of the patients within 3 months.


2005 ◽  
Vol 71 (10) ◽  
pp. 837-840 ◽  
Author(s):  
Zuri A. Murrell ◽  
Matthew R. Dixon ◽  
Hernan Vargas ◽  
Tracey D. Arnell ◽  
Ravin Kumar ◽  
...  

The purpose of this study was to review and characterize the indications and early outcomes of abdominoperineal resection (APR) when used in a colorectal practice in an academic setting. Data was collected from the charts of all patients undergoing APR in a retrospective manner. Data collected included demographic information and details regarding the clinical presentation. Operative factors, information regarding the postoperative course, and morbidity and mortality were evaluated. Forty-four patients were treated with an APR in this practice between the years 1992 and 2004. The indications for operation were primary rectal cancer (n = 31), recurrent rectal cancer (n = 6), intractable Crohn disease (n = 3), anal melanoma (n = 1), cloacogenic cancer (n = 1), squamous cell cancer (n = 1), and gastrointestinal stromal tumor (n = 1). Complications in the first 60 days affected 14 patients (32%). The most common complication was intra-abdominal/pelvic abscess formation occurring in 6 of these 14 patients (43%). Additional complications in the first 60 days included rectus flap necrosis, perineal wound evisceration, prolonged ileus, and urinary retention. There was no surgical mortality. Long-term complications occurred in 7 patients (16%), with parastomal hernia being the most common (43%). Although relatively infrequently used, APR will continue to play a role for selected patients in the future. Despite the significant morbidity associated with this surgery, APR may provide beneficial treatment for select cases of low rectal cancer, end-stage inflammatory bowel disease, and anal malignancies.


Sign in / Sign up

Export Citation Format

Share Document